After a couple of failed attempts at acquisitions and sales among the six dominant companies on the global market of the hearing devices industry – also known as ‘The Big Six’ – the last couple of years have been relatively calm in that area of the industry. At present the battle is fought for research, development and expansion within related industry areas and in the retail branch.
From the middle of the 1990s and through the following decade – particularly the period from 1999 to 2001 – a number of fusions and acquisitions were carried out globally. In 2006 Sonova tried to buy out GN Resound, but the attempt was curbed by German competition authorities and fell through. Some years later Siemens indicated – ultimately unsuccessfully - that it was for sale, but no one met their asking price - perhaps they had Sonova’s failed attempt in mind. So for some time there has been, according to one source within the business, a kind of stand still where most companies hope and believe in the possibility of remaining among the best. However, William Demant acquired Otix Global towards the end of 2010 – Otix owned, e.g., the small hearing device-brand Sonic, which today is a part of the company portfolio along with the somewhat larger brands Oticon and Bernafon.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer.
Start et gratis virksomhedsprøveabonnementMere fra MedWatch
Vækstfonden investerer i biotekstartup
Frisk kapital fra blandt andre Vækstfonden skal bringe opstartsvirksomheden GLX Analytix fra forskning til kommercialisering.
Her er de vigtigste nyheder fra MedWatch i uge 26
Fujifilm investerer 11 mia. kr. i sin nordsjællandske fabrik, Fruergaard står med nøgleroller i Bruxelles og Life science-branche har sparket døren ind til Christiansborg.
Sådan udkommer MedWatch i løbet af sommeren
I de kommende uger udkommer MedWatch kun med ét dagligt nyhedsbrev.
Bavarian Nordic skal levere yderligere 2,5 mio. vacciner til USA
Leverancerne vil starte i fjerde kvartal 2022 og fortsætte ind i 2023, hvor hovedparten af doserne vil blive leveret.
Dansk Biotek skifter navn
Den danske brancheorganisation for biotekselskaber, Dansk Biotek, skifter navn til "Danish Bio - Dansk Biotek" for at imødekomme den stigende internationalisering af branchen, fortæller formand.
Scientific Writer 
Director Regulatory Affairs 
Principal Laboratory Technologist Medicinal Chemistry 
Associate, Regulatory Affairs Life Cycle Management 
Senior Toxicologist 
Open position for a Clinical Trial Manager to join our team at Nykode! 
Chair of the Board 
Project Managers keep all of us healthy 
Global Product Manager - Pulmonology 
Nordic Medical Advisor 
Folketidende i gear! 
Ejendomsadministrator til egne kontorejendomme 
Projektleder med fokus på regnskab og ERP til Grønland 
Ejendomsadministrator til andels- og ejerforeninger. 
Technology Engineer for LEGO® House, Billund